Filing Details

Accession Number:
0001312548-12-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-01-17 18:00:41
Reporting Period:
2012-01-12
Filing Date:
2012-01-17
Accepted Time:
2012-01-17 18:00:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1323885 Atricure Inc. ATRC Surgical & Medical Instruments & Apparatus (3841) 341940305
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1312548 Discovery Group I, Llc 191 N. Wacker Drive Suite 1685
Chicago IL 60606
No No Yes No
1323510 R Michael Murphy C/O Discovery Group I, Llc
191 N. Wacker Drive Suite 1685
Chicago IL 60606
No No Yes No
1323511 J Daniel Donoghue C/O Discovery Group I, Llc
191 N. Wacker Drive Suite 1685
Chicago IL 60606
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-01-12 2,545 $11.20 249,018 No 4 S Indirect By Pleiades Investment Partners - D, L.P
Common Stock Acquisiton 2012-01-13 4,400 $11.17 244,618 No 4 S Indirect By Pleiades Investment Partners - D, L.P
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Pleiades Investment Partners - D, L.P
No 4 S Indirect By Pleiades Investment Partners - D, L.P
Footnotes
  1. Discovery Group I, LLC is an investment manager for Pleiades Investment Partners - D, L.P., which is a discretionary client of the reportingperson, that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to theextent of its pecuniary interest therein
  2. This transaction was executed in multiple trades at prices ranging from $11.10 to $11.30. The price reported above reflects the weightedaverage purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected
  3. This transaction was executed in multiple trades at prices ranging from $11.15to $11.30. The price reported above reflects the weightedaverage purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected